Back to search

Effect of Intensive Versus Standard Blood Pressure Control on Depression and Health-Related Quality of Life in Type 2 Diabetes

Data up to Jan 2025

Published2012
Citations21
References16

Total Citations Per Year

Abstract

References (16)

Validation and Utility of a Self-report Version of PRIME-MD<SUBTITLE>The PHQ Primary Care Study</SUBTITLE>

1999 • 8,780 citations

The MOS 36-Item Short-Form Health Survey (SF-36)

1993 • 6,519 citations

Effects of Intensive Blood-Pressure Control in Type 2 Diabetes Mellitus

2010 • 3,333 citations

Effects of a fixed combination of perindopril and indapamide on macrovascular and microvascular outcomes in patients with type 2 diabetes mellitus (the ADVANCE trial): a randomised controlled trial

2007 • 1,978 citations

The J-Curve Phenomenon in Hypertension

2016 • 1,513 citations

Handbook of Psychology and Diabetes

2013 • 654 citations

Action to Control Cardiovascular Risk in Diabetes (ACCORD) Trial: Design and Methods

2007 • 594 citations

Levels and Risks of Depression and Anxiety Symptomatology Among Diabetic Adults

1997 • 502 citations

Quality of life in type 2 diabetic patients is affected by complications but not by intensive policies to improve blood glucose or blood pressure control (UKPDS 37). U.K. Prospective Diabetes Study Group.

1999 • 422 citations

Health Economic Benefits and Quality of Life During Improved Glycemic Control in Patients With Type 2 Diabetes Mellitus

1998 • 421 citations

Patient Perceptions of Quality of Life With Diabetes-Related Complications and Treatments

2007 • 274 citations

Health-related quality of life and hypertension: a systematic review and meta-analysis of observational studies

2010 • 250 citations

Relationships of Quality-of-Life Measures to Long-term Lifestyle and Drug Treatment in the Treatment of Mild Hypertension Study

1997 • 206 citations

Relationship between obesity, hypertension and diabetes, and health-related quality of life among the elderly

2007 • 108 citations

Combined intensive blood pressure and glycemic control does not produce an additive benefit on microvascular outcomes in type 2 diabetic patients

2011 • 61 citations

Health-Related Quality of Life and Cost-Effectiveness Components of the Action to Control Cardiovascular Risk in Diabetes (ACCORD) Trial: Rationale and Design

2007 • 27 citations

Cited By (0)

Loading...